Physician profile
Vadim Guy
NPI 1205119120
$31,014.43
in general payments reported to CMS, 2019-2025
21 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $731 · 2021: $12K · 2022: $15K · 2023: $848 · 2024: $653 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,151 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $350 · Consulting Fee: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,151.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $350.00 |
| Consulting Fee | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clerio Vision, INC | $15,125.00 | 2020-2022 | |
| Visioneering Technologies, INC. | $10,780.00 | 2021 | |
| Coopervision INC. | $1,176.78 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $827.66 | 2019-2025 | Acuvue |
| Sight Sciences, INC. | $567.68 | 2020-2025 | Tearcare System |
| Bausch & Lomb Americas INC. | $539.64 | 2023-2025 | Infuse, Xiidra, Miebo |
| Alcon Vision LLC | $465.39 | 2021-2025 | Precision 1, Clareon, Tryptyr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $296.08 | 2019-2021 | |
| Biotissue Holdings INC. | $255.70 | 2019-2023 | |
| Lkc Technologies, INC. | $246.77 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $202.29 | 2020-2025 | Cequa |
| Hoffmann-La Roche Limited | $125.00 | 2019 | |
| Dompe US, INC. | $123.89 | 2022 | |
| Topcon Healthcare, INC. | $104.02 | 2021 | |
| Abb Con-Cise Optical Group LLC | $47.24 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Oyster Point Pharma, INC. | $22.31 | 2022 | |
| Kala Pharmaceuticals, INC. | $21.87 | 2021 | |
| Allergan, INC. | $18.93 | 2021 | |
| Harrow Eye, LLC | $16.88 | 2025 | Vevye |
| Maculogix, INC. | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vadim Guy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.